诺瓦瓦克斯医药2024财年实现净利润-1.87亿美元,同比增加65.69%

市场透视
08 Mar

3月8日,诺瓦瓦克斯医药(NVAX.US)公布财报,公告显示公司2024财年净利润为-1.87亿美元,同比增加65.69%;其中营业收入为6.82亿美元,同比减少30.69%,每股基本收益为-1.23美元。从资产负债表来看,诺瓦瓦克斯医药(NVAX.US)总负债22.27亿美元,其中短期债务17.10百万美元,资产负债比为0.72,流动比率为0.98。机构评级:截至2025年3月8日,当前有7家...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10